Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Bristol Myers Squibb
Bristol Myers Squibb
Biopharma’s bolt-on bonanza is set to continue
EP Vantage
Thu, 01/12/23 - 10:18 am
M&A
Amgen
AstraZeneca
Bristol Myers Squibb
GSK
Ipsen
Merck
Pfizer
JPM23: Takeda tests Bristol Myers, Prime weighs spinoffs and Sanofi faces down a competitor
BioPharma Dive
Wed, 01/11/23 - 11:08 pm
JPMHC 2023
Takeda
Bristol Myers Squibb
Prime Medicine
Sanofi
Lilly, Biogen and more gear up for blockbuster launches in 2023: report
Fierce Pharma
Wed, 01/11/23 - 11:00 pm
Clarivate
drug launches
Eli Lilly
Biogen
GSK
Bristol Myers Squibb
JPM Day 1: Highlights
BioSpace
Mon, 01/9/23 - 11:01 pm
JPMHC 2023
Sarepta Therapeutics
Biomarin
Alnylam
JNJ
Arrowhead Pharmaceuticals
Novartis
Bristol Myers Squibb
Biopharmas left Black and Latinx patients behind in oncology clinical trials, nonprofit says
Fierce Biotech
Thu, 01/5/23 - 10:09 am
clinical trials
clinical trial diversity
oncology
Sanofi
United Therapeutics
Bristol Myers Squibb
Biopharma’s 5 Biggest M&A Deals of 2022
BioSpace
Wed, 12/14/22 - 10:50 am
M&A
Amgen
Horizon Therapeutics
Pfizer
Biohaven
Global Blood Therapeutics
Bristol Myers Squibb
Turning Point Therapeutics
ChemoCentryx
ASH: Bristol's 3rd-line Abecma data didn't make the trip to New Orleans. Is it cause for concern?
Fierce Pharma
Mon, 12/12/22 - 10:59 pm
Bristol Myers Squibb
ASH 2022
Abecma
clinical trials
Multiple Myeloma
ASH: In next BCMA myeloma race, Gracell dazzles with 100% response rate as Pfizer, BMS place their bets
Fierce Biotech
Mon, 12/12/22 - 10:33 am
ASH 2022
Gracell
CAR-T
Multiple Myeloma
Bristol Myers Squibb
Pfizer
ASH: Bristol Myers bolsters Breyanzi's case in earlier lymphoma amid clash with Gilead
Fierce Pharma
Mon, 12/12/22 - 10:16 am
Bristol Myers Squibb
Breyanzi
B-cell lymphoma
CAR-T
ASH 2022
Compugen COM701 in dual/triple combo shows promise in ovarian cancer patients in trial
Seeking Alpha
Tue, 12/6/22 - 10:31 am
CompuGen
COM701
Bristol Myers Squibb
Opdivo
ovarian cancer
platinum-resistant ovarian cancer
BMS' Zeposia and AbbVie's Skyrizi Shake Up First-Line Prescribing Patterns in the US Ulcerative Colitis and Crohn's Disease Markets, Spherix Reports
PR Newswire
Sun, 12/4/22 - 01:24 pm
Bristol Myers Squibb
AbbVie
Zeposia
Skyrizi
ulcerative colitis
Crohn's Disease
gastroentrologists
Regeneron's Libtayo posts lung cancer win with Bristol's Yervoy. But company won't seek approval
Fierce Pharma
Thu, 12/1/22 - 07:11 pm
Regeneron
Libtayo
non-small cell lung cancer
Bristol Myers Squibb
Yervoy
Nimbus on cloud 9 as psoriasis data support taking rival to Bristol Myers' Sotyktu into phase 3
Fierce Biotech
Wed, 11/30/22 - 10:38 am
Nimbus Therapeutics
Sotyktu
Bristol Myers Squibb
clinical trials
NDI-034858
Bristol Myers has change of heart on cardiovascular gene therapy pact, terminating uniQure deal
Fierce Biotech
Tue, 11/29/22 - 10:57 am
Bristol Myers Squibb
uniQure
gene therapy
Envisagenics Announces Research Collaboration with Bristol Myers Squibb
BioSpace
Tue, 11/29/22 - 10:40 am
Envisagenics
artificial intelligence
Bristol Myers Squibb
R&D
Lyvgen and BMS partner for Phase II lung cancer antibody trial
Clinical Trials Arena
Mon, 11/28/22 - 10:18 am
Lyvgen
Bristol Myers Squibb
clinical trials
LVGN7409
non-small cell lung cancer
'Monopoly' allowed Bristol Myers and generics makers to 'steal' from Revlimid purchasers, lawsuit says
Fierce Pharma
Wed, 11/23/22 - 07:33 am
Bristol Myers Squibb
Celgene
Revlimid
patents
generics
Bristol Myers Squibb Threatens New Rules Will Hinder Drug Production
Motley Fool
Mon, 11/21/22 - 09:55 am
Bristol Myers Squibb
drug development
Inflation Reduction Act
Gilead dodges Supreme Court review—and a $1.2B fine—in CAR-T patent feud with Bristol Myers
Fierce Pharma
Mon, 11/7/22 - 05:48 pm
Gilead Sciences
Kite Pharma
Bristol Myers Squibb
cell therapy
legal
CAR-T
Yescarta
Nimbus hopes to best Bristol’s Sotyktu
EP Vantage
Fri, 11/4/22 - 10:15 am
Bristol Myers Squibb
Sotyktu
Nimbus
NDI-034858
psoriasis
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »